Compass Financial Management
DARE icon

Compass Financial Management’s Dare Bioscience DARE Stock Holding History

Compass Financial Management’s Portfolio DARE Stock Details DARE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$4 Buy
+5
New +$6 ﹤0.01% 1723

Other funds holding DARE

Garde Capital
Garde Capital Seattle, Washington $1.8B AUM 11.9% 1-Year Est. Return
Farther Finance Advisors
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
IFS Advisors
IFS Advisors Overland Park, Kansas $332M AUM 8.56% 1-Year Est. Return
SBI Securities
SBI Securities Tokyo, Japan $4.38B AUM 56.37% 1-Year Est. Return
Mather Group
Mather Group Chicago, Illinois $11.8B AUM 12.84% 1-Year Est. Return
Inspire Investing
Inspire Investing Meridian, Idaho $2.37B AUM 29.82% 1-Year Est. Return
Putney Financial Group
Putney Financial Group San Rafael, California $127M AUM 39.3% 1-Year Est. Return

Compass Financial Management's DARE Position: Q3 2026 in Review

Compass Financial Management opened a new position in Dare Bioscience (DARE) in Q3 2026: 5 shares worth $4. The stake represents ﹤0.01% of the portfolio and ranks #1723 among its holdings.

8 funds tracked by Wall St. Rank hold DARE as of Q3 2026.

  • Compass Financial Management held 5 shares of Dare Bioscience worth $4 as of Q3 2026.
  • Dare Bioscience was a new Compass Financial Management position in Q3 2026.
  • Dare Bioscience made up ﹤0.01% of Compass Financial Management's portfolio in Q3 2026, its #1723 holding.
  • 8 funds tracked by Wall St. Rank held Dare Bioscience as of Q3 2026.

Based on Compass Financial Management's 13F filing for Q3 2026, filed 30 Oct 2026.